73 related articles for article (PubMed ID: 19153100)
1. CAG repeat polymorphism of the MEF2A gene is not associated with the risk of coronary artery disease among Taiwanese.
Hsu LA; Chang CJ; Teng MS; Semon Wu ; Hu CF; Chang WY; Ko YL
Clin Appl Thromb Hemost; 2010 Jun; 16(3):301-5. PubMed ID: 19153100
[TBL] [Abstract][Full Text] [Related]
2. Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease.
Guella I; Rimoldi V; Asselta R; Ardissino D; Francolini M; Martinelli N; Girelli D; Peyvandi F; Tubaro M; Merlini PA; Mannucci PM; Duga S
Circ Cardiovasc Genet; 2009 Apr; 2(2):165-72. PubMed ID: 20031581
[TBL] [Abstract][Full Text] [Related]
3. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.
González P; García-Castro M; Reguero JR; Batalla A; Ordóñez AG; Palop RL; Lozano I; Montes M; Alvarez V; Coto E
J Med Genet; 2006 Feb; 43(2):167-9. PubMed ID: 15958500
[TBL] [Abstract][Full Text] [Related]
4. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population.
Han Y; Yang Y; Zhang X; Yan C; Xi S; Kang J
Clin Chem Lab Med; 2007; 45(8):987-92. PubMed ID: 17579569
[TBL] [Abstract][Full Text] [Related]
5. MEF2A gene and susceptibility to coronary artery disease in the Chinese people.
Yuan H; Lü HW; Hu J; Chen SH; Yang GP; Huang ZJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):453-7. PubMed ID: 16951497
[TBL] [Abstract][Full Text] [Related]
6. Myocyte enhancing factor-2A in Alzheimer's disease: genetic analysis and association with MEF2A-polymorphisms.
González P; Alvarez V; Menéndez M; Lahoz CH; Martínez C; Corao AI; Calatayud MT; Peña J; García-Castro M; Coto E
Neurosci Lett; 2007 Jan; 411(1):47-51. PubMed ID: 17112666
[TBL] [Abstract][Full Text] [Related]
7. Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis.
Liu Y; Niu W; Wu Z; Su X; Chen Q; Lu L; Jin W
PLoS One; 2012; 7(2):e31406. PubMed ID: 22363637
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between the MEF2A gene and myocardial infarction.
Lieb W; Mayer B; König IR; Borwitzky I; Götz A; Kain S; Hengstenberg C; Linsel-Nitschke P; Fischer M; Döring A; Wichmann HE; Meitinger T; Kreutz R; Ziegler A; Schunkert H; Erdmann J
Circulation; 2008 Jan; 117(2):185-91. PubMed ID: 18086930
[TBL] [Abstract][Full Text] [Related]
9. MEF2A sequence variants in Turkish population.
Gulec S; Ruchan Akar A; Akar N
Clin Appl Thromb Hemost; 2008 Oct; 14(4):465-7. PubMed ID: 18160598
[TBL] [Abstract][Full Text] [Related]
10. MEF2A sequence variants and coronary artery disease: a change of heart?
Altshuler D; Hirschhorn JN
J Clin Invest; 2005 Apr; 115(4):831-3. PubMed ID: 15841171
[TBL] [Abstract][Full Text] [Related]
11. Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family.
Maiolino G; Colonna S; Zanchetta M; Pedon L; Seccia TM; Cesari M; Vigili de Kreutzenberg S; Avogaro A; Rossi GP
Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):557-60. PubMed ID: 21450604
[TBL] [Abstract][Full Text] [Related]
12. Structural changes in exon 11 of MEF2A are not related to sporadic coronary artery disease in Han Chinese population.
Dai DP; Zhou XY; Xiao Y; Xu F; Sun FC; Ji FS; Zhang ZX; Hu JH; Guo J; Zheng JD; Dong JM; Zhu WG; Shen Y; Qian YJ; He Q; Cai JP
Eur J Clin Invest; 2010 Aug; 40(8):669-77. PubMed ID: 20546016
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic trinucleotide repeat in the MEF2A gene at 15q26 is not expanded in familial cardiomyopathies.
Bachinski LL; Abchee A; Durand JB; Roberts R; Krahe R; Hobson GM
Mol Cell Probes; 1997 Feb; 11(1):55-8. PubMed ID: 9076715
[TBL] [Abstract][Full Text] [Related]
14. No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease.
Eikelboom JW; Baker RI; Parsons R; Taylor RR; van Bockxmeer FM
Thromb Haemost; 1998 Dec; 80(6):878-80. PubMed ID: 9869153
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study.
Pfohl M; Koch M; Prescod S; Haase KK; Häring HU; Karsch KR
Eur Heart J; 1999 Sep; 20(18):1318-25. PubMed ID: 10462466
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
17. Analysis of MEF2A mutations in a Chinese population with premature coronary artery disease.
Dai Y; Zhang S; Wu W
Genet Test Mol Biomarkers; 2013 Apr; 17(4):352-5. PubMed ID: 23461724
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
[TBL] [Abstract][Full Text] [Related]
19. Miscues on the "lack of MEF2A mutations" in coronary artery disease.
Wang Q; Rao S; Topol EJ
J Clin Invest; 2005 Jun; 115(6):1399-400; author reply 1400-1. PubMed ID: 15931371
[No Abstract] [Full Text] [Related]
20. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
